Cargando…

Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction

There is mounting evidence that Parkinson’s disease (PD) and Alzheimer’s disease (AD) share neuropathological hallmarks, while similar types of biomarkers are being applied to both. In this review we aimed to explore similarities and differences between PD and AD at both the neuropathology and the b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Compta, Yaroslau, Revesz, Tamas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990431/ https://www.ncbi.nlm.nih.gov/pubmed/33325398 http://dx.doi.org/10.3233/JPD-202323

Ejemplares similares

Alzheimer disease neuropathology: understanding autonomic dysfunction
por: Engelhardt, Eliasz, et al.
Publicado: (2008)

Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction
por: Petrov, A. M., et al.
Publicado: (2017)

Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease
por: Agnello, Luisa, et al.
Publicado: (2021)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
por: Guo, Peng, et al.
Publicado: (2020)

Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology
por: Chen, Fading, et al.
Publicado: (2021)

Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology
por: Maarouf, Chera L., et al.
Publicado: (2013)

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
por: Smirnov, Denis S., et al.
Publicado: (2022)

The neuropathological diagnosis of Alzheimer’s disease
por: DeTure, Michael A., et al.
Publicado: (2019)

Patterns of cortical thinning in nondemented Parkinson's disease patients
por: Uribe, Carme, et al.
Publicado: (2016)

Ghrelin Bridges DMV Neuropathology and GI Dysfunction in the Early Stages of Parkinson's Disease
por: Liu, Yizhen, et al.
Publicado: (2022)

Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
por: Zou, Li, et al.
Publicado: (2021)

The Neuropathologic Substrate of Parkinson Disease Dementia
por: Jellinger, Kurt A.
Publicado: (2009)

Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson's Disease
por: Vallderiola, Francesc, et al.
Publicado: (2015)

Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer’s Disease from Other Neurological Disorders
por: Piccoli, Tommaso, et al.
Publicado: (2022)

Over-Mutated Mitochondrial, Lysosomal and TFEB-Regulated Genes in Parkinson’s Disease
por: Segur-Bailach, Eulàlia, et al.
Publicado: (2022)

Alzheimer's disease: synaptic dysfunction and Aβ
por: Shankar, Ganesh M, et al.
Publicado: (2009)

Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
por: Tönnies, Eric, et al.
Publicado: (2017)

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease
por: Amadoru, Sanka, et al.
Publicado: (2020)

Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
por: Doher, Nicholas, et al.
Publicado: (2023)

Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer’s disease neuropathologic change
por: Scaduto, Pietro, et al.
Publicado: (2022)

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Discriminating cognitive status in Parkinson’s disease through functional connectomics and machine learning
por: Abós, Alexandra, et al.
Publicado: (2017)

Gray/White Matter Contrast in Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
por: Furderer, Makaila L., et al.
Publicado: (2022)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Editorial: The synaptic basis of neuropathology
por: Nugent, Fereshteh S., et al.
Publicado: (2022)

Microglia Activation in the Brain as Inflammatory Biomarker of Alzheimer’s Disease Neuropathology and Clinical Dementia
por: Xiang, Zhongmin, et al.
Publicado: (2006)

Neuropathology and Neurochemistry of Nonmotor Symptoms in Parkinson's Disease
por: Ferrer, Isidro
Publicado: (2011)

Secretome as neuropathology-targeted intervention of Parkinson’s disease
por: Ardianto, Christian, et al.
Publicado: (2022)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
por: Xia, Yuxing, et al.
Publicado: (2020)

The Effect of Aggregated Alpha Synuclein on Synaptic and Axonal Proteins in Parkinson’s Disease—A Systematic Review
por: Murphy, Jennifer, et al.
Publicado: (2022)

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
por: Rabinovici, Gil D., et al.
Publicado: (2016)

Dysfunctional Mitochondrial Bioenergetics and Synaptic Degeneration in Alzheimer Disease
por: Tang, Jason, et al.
Publicado: (2019)

Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
por: Perdigão, Catarina, et al.
Publicado: (2020)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Wu, Moxin, et al.
Publicado: (2021)

Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
por: Silva, Jaime, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6b9ejur1um48a0dknc43ja8coo